3 US Growth Stocks With High Insider Ownership

As the U.S. stock market continues to rally, with major indices like the S&P 500 and Nasdaq Composite opening higher, investors are keenly observing how earnings reports and economic indicators influence market sentiment. In this environment, growth companies with high insider ownership often attract attention due to the potential alignment of interests between management and shareholders, making them intriguing prospects in a fluctuating market landscape.

Top 10 Growth Companies With High Insider Ownership In The United States

Name	Insider Ownership	Earnings Growth
Atour Lifestyle Holdings (NasdaqGS:ATAT)	26%	25.7%
Super Micro Computer (NasdaqGS:SMCI)	14.4%	24.3%
On Holding (NYSE:ONON)	19.1%	29.6%
Coastal Financial (NasdaqGS:CCB)	18%	46.1%
Clene (NasdaqCM:CLNN)	21.6%	60.2%
EHang Holdings (NasdaqGM:EH)	32.8%	81.5%
Credo Technology Group Holding (NasdaqGS:CRDO)	13.7%	95%
Alkami Technology (NasdaqGS:ALKT)	11%	98.6%
Credit Acceptance (NasdaqGS:CACC)	14.1%	50%
BBB Foods (NYSE:TBBB)	22.9%	50.7%

Click here to see the full list of 206 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Let's dive into some prime choices out of the screener.

Astrana Health (NasdaqCM:ASTH)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Astrana Health, Inc. is a physician-centric, technology-powered healthcare management company that provides medical care services in the United States with a market cap of approximately $2.07 billion.

Operations: Astrana Health's revenue segments include Care Delivery at $140.38 million, Care Partners at $1.64 billion, and Care Enablement at $143.75 million.

Insider Ownership: 12.8%

Earnings Growth Forecast: 20.2% p.a.

Astrana Health is experiencing significant growth, with earnings and revenue forecasted to increase over 20% annually, surpassing the US market's average. Despite past shareholder dilution and recent lowered guidance for 2024, the company's revenue rose to US$478.71 million in Q3 from US$348.17 million a year ago. Analysts predict a substantial stock price increase of 58.3%. Recent M&A activity includes an agreement to acquire Prospect Health, indicating strategic expansion efforts.

• Delve into the full analysis future growth report here for a deeper understanding of Astrana Health.
• Our comprehensive valuation report raises the possibility that Astrana Health is priced higher than what may be justified by its financials.

Canadian Solar (NasdaqGS:CSIQ)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Canadian Solar Inc., along with its subsidiaries, offers solar energy and battery storage products and solutions across Asia, the Americas, Europe, and globally, with a market cap of approximately $788.01 million.

Operations: The company's revenue segments include $6.58 billion from CSI Solar and $207.51 million from Recurrent Energy.

Insider Ownership: 21.2%

Earnings Growth Forecast: 59.8% p.a.

Canadian Solar's earnings are expected to grow significantly, outpacing the US market despite lower profit margins compared to last year. The company's revenue growth of 13.9% annually is above the US market average, although it faces legal challenges from Trina Solar over patent issues. With a price-to-earnings ratio of 23.6x below industry averages, Canadian Solar remains an attractive valuation despite its volatile share price and past shareholder dilution concerns.

• Dive into the specifics of Canadian Solar here with our thorough growth forecast report.
• According our valuation report, there's an indication that Canadian Solar's share price might be on the expensive side.

Cadre Holdings (NYSE:CDRE)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Cadre Holdings, Inc. manufactures and distributes safety products for protection in hazardous situations both in the United States and internationally, with a market cap of approximately $1.36 billion.

Operations: The company's revenue segments include $449.48 million from Product and $99.39 million from Distribution.

Insider Ownership: 35.3%

Earnings Growth Forecast: 27.4% p.a.

Cadre Holdings is experiencing significant earnings growth, projected at 27.4% annually, surpassing the US market average. Despite a recent decline in quarterly sales and net income, insider activity shows substantial buying over the past three months. The company anticipates full-year sales between US$560 million and US$571 million for 2024. Trading at a considerable discount to its estimated fair value, Cadre's revenue is forecasted to grow faster than the broader market rate of 8.9%.

• Take a closer look at Cadre Holdings' potential here in our earnings growth report.
• The valuation report we've compiled suggests that Cadre Holdings' current price could be quite moderate.

Turning Ideas Into Actions

• Explore the 206 names from our Fast Growing US Companies With High Insider Ownership screener here.
• Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
• Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com